APPENDIX: TRACKING FORMS & TEMPLATES
Appendix E
Biomarker Tracking Log
_________________________________________________________________________

Update at each blood test or clinical review. Target: every 3–6 months during active transformation; annually at maintenance.

Name: _________________ DOB: _____________ Physician: _________________

Biomarker Optimal target Date: _______ Date: _______ Date: _______ Trend
Body Composition
Body weight (kg) Goal: _______
BMI 18.5–24.9
Waist circumference (cm) Men < 90 / Women < 80
Metabolic
Fasting glucose (mg/dL) < 100
Fasting insulin (µIU/mL) 2–6
HbA1c (%) < 5.7
HOMA-IR < 1.0
Lipids
Total cholesterol (mg/dL) < 200
LDL-C (mg/dL) < 100
HDL-C (mg/dL) Men > 40 / Women > 50
Triglycerides (mg/dL) < 150
ApoB (mg/dL) < 80
Inflammation
hs-CRP (mg/L) < 1.0
Hormonal
TSH (thyroid) 0.5–2.5 mIU/L
Testosterone total (men) (ng/dL) 400–900
Estradiol (women) (pg/mL) Cycle-dependent
DHEA-S Age-appropriate
Cortisol (AM, fasting) (µg/dL) 6–23
Micronutrients
Vitamin D (25-OH) (ng/mL) 40–60
Ferritin (ng/mL) Men 30–300 / Women 20–200
B12 (pg/mL) > 400
Magnesium (mg/dL) 1.7–2.2
Zinc (µg/dL) 60–120
Cardiovascular
Blood pressure (mmHg) < 120/80
Resting heart rate (bpm) 50–70
VO₂ max estimate (mL/kg/min) Age-appropriate

Physician notes / medication changes:

All chapters